Suppressive action of pituitary adenylate cyclase activating polypeptide (PACAP) on proliferation of immature mouse Leydig cell line TM3 cells

Biomedical Research

Volumn 29, Issue 6, 2008, Pages 321-330

  Matsumoto, Shoji ^a   Arakawa, Yukio ^b   Ohishi, Masako ^a   Yanaihara, Hitoshi ^c   Iwanaga, Toshihiko ^d   Kurokawa, Nobuo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; TESTOSTERONE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL CLONE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL SPECIFICITY; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; GENETIC PROCEDURES; LEYDIG CELL; MALE; MITOSIS INHIBITION; MOUSE; NONHUMAN; PHASE CONTRAST MICROSCOPY; REAL TIME CELL ELECTRONIC SENSING SYSTEM; SERTOLI CELL; STEROIDOGENESIS; TESTOSTERONE RELEASE; ANIMAL; BAGG ALBINO MOUSE; CELL CYCLE; CELL LINE; CELL SHAPE; CYTOLOGY; GENETICS; METABOLISM;

MUS;

ANIMALS; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELL SHAPE; CYCLIC AMP; LEYDIG CELLS; MALE; MICE; MICE, INBRED BALB C; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; SERTOLI CELLS; TESTOSTERONE;

EID: 59649088416     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.29.321     Document Type: Article

References (35)

1. Abassi YA, Jackson JA, Zhu J, O'Connell J, Wang X and Xu X (2004) Label-free, real-time monitoring of IgE-mediated mast cell activation on microelectronic cell sensor arrays. J Immunol Methods 29, 2195-2205.
2. Arakawa Y, Takao E, Hirotani Y, Kato I, Li J, Yanaihara N, Yanaihara C, Iwanaga T and Kurokawa N (2002) Immunochemical characterization and measurement of neuronal type nitric oxide synthase in human neuroblastoma NB-OK-1 cell using novel anti-synthetic peptide antibody and specific immunoassay system. Regul Pept 106, 115-123.
3. Arimura A, Somogyvári-Vigh A, Miyata A and Mizuno K, Coy DH and Kitada C (1991) Tissue distribution of PACAP as determined by RIA: Highly abundant in the rat brain and testis. Endocrinology 129, 2787-2789.
4. Banks WA, Kastin AJ, Komaki G and Arimura A (1993) Pituitary adenylate cyclase activating polypeptide (PACAP) can cross the vascular component of the blood-testis barrier in the mouse. J Androl 14, 170-173.
5. Buscail L, Gourlet P, Cauvin A, Neef PD, Gossen D, Arimura A, Miyata A, Coy DH, Robberecht P and Christophe J (1990) Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR4-2J. FEBS Lett 262, 77-81.
6. Cauvin A, Buscail L, Gourlet P, De Neef P, Gossen D, Arimura A, Miyata A, Coy DH, Robberecht P and Christophe J (1990) The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK. Peptides 11, 773-777.
7. El-Gehani F, Tena-Sempere M and Huhtaniemi I (2000) Evidence that pituitary adenylate cyclase-activating polypeptide is a potent regulator of fetal rat testicular steroidogenesis. Biol Reprod 63, 1482-1489.
8. El-Gehari F, Zhang F-P, Pakarinen P, Rannikko A and Huhtamemi I (1998) Gonadotropin-independent regulation of the testicular steroidogenesis in the fetal rat. Biol Reprod 58, 116-123.
9. Gottschall PE, Tatsuno I, Miyata A and Arimura A (1990) Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide. Endocrinology 127, 272-277.
10. Goursaud S, Maloteaux J-M and Hermans E (2008) Activation of VIP/PACAP type 2 receptor by the peptide histidine isoleucine in astrocytes influences GLAST-mediated glutamate uptake. J Neurochem 105, 1165-1175.
11. Hannibal J and Fahrenkrug J (1995) Expression of pituitary adenylate cyclase activating polypeptide (PACAP) gene by rat spermatogenic cells. Regul Pept 55, 111-115.
12. Heindel JJ, Powell CJ, Paschall CS, Arimura A and Culler MD (1992) A novel hypothalamic peptide, pituitary adenylate cyclase-activating peptide, modulates Sertoli cell function in vitro. Biol Reprod 47, 800-806.
13. Hoshino M, Li M, Zheng LQ, Suzuki M, Mochizuki T and Yanaihara N (1993) Pituitary adenylate cyclase activating peptide and vasoactive intestinal polypeptide: differentiation effects on human neuroblastoma NB-OK-1 cells. Neurosci Lett 159, 35-38.
14. Hurley JD, Gardiner JV, Jones PM and Bloom SR (1995) Cloning and molecular characterization of complementary deoxyribonucleic acid corresponding to a novel form of pituitary adenylate cyclase-activating polypeptide messenger ribonucleic acid in the rat testis. Endocrinology 136, 550-557.
15. Koh PO, Noh HS, Kim YS, Cheon EW, Kim HJ, Kang SS, Cho GJ and Choi WS (2003) Cellular localization of pituitary adenylate cyclase-activating polypeptide in the rat testis. Mol Cells 15, 271-276.
16. Kononen J, Paavola M, Penttila T-L, Parvinen M and Pelto-Huikko M (1994) Stage-specific expression of pituitary adenylate cyclase activating polypeptide. (PACAP) mRNA in the rat seminiferous tubules. Endocrinology 135, 2291-2294.
17. Krempels K, Usdin TB, Harta G and Mezey E (1995) PACAP acts through VIP type 2 receptors in the rat testis. Neuropeptides 29, 315-320.
18. Kurokawa N, Matsumoto S, Sawada M, Mochizuki T, Yanaihara N, Arakawa Y and Yanaihara C (1996) VIP release from human neuroblastoma cells by bifemelane and indeloxazine. Biomed Res 17, 261-264.
19. Leliévre V, Pineau N, Du J, Wen C-H, Nguyen T, Janet T, Muller J-M and Waschek JA (1998) Differential effects of peptide histidine isoleucine (PHI) and related peptides on stimulation and suppression of neuroblastoma cell proliferation. J Biol Chem 273, 19685-19690.
20. Lu N and Dicicco-Bloom E (1997) Pituitary adenylate cyclase-activating polypeptide is an autocrine inhibitor of mitosis in cultured cortical precursor cells. Proc Natl Acad Sci USA 94, 3357-3362.
21. Mather JP (1980) Establishment and characterization of two distinct mouse testicular epithelial cell lines. Biol Reprod 23, 243-252.
22. Mather JP, Zhuang L-Z, Perez-Infante V and Phillips DM (1982) Culture of testicular cells in hormone-supplemented serum-free medium. Ann NY Acad Sci 383, 44-68.
23. Miampamba M, Germano PM, Arli S, Wong HH, Scott D, Taché Y and Pisegna JR (2002) Expression of pituitary adenylate cyclase-activating polypeptide and PACAP type 1 receptor in the rat gastric and colonic myenteric neurons. Regul Pept 105, 145-154.
24. Miyata A, Arimura A, Dahl RR Minamino N, Uehara A, Jiang L, Culler MD and Coy DH (1989) Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164, 567-574.
25. Miyata A, Jiang L, Dahl RD, Kitada C, Kubo K, Fujino M, Minamino N and Arimura A (1990) Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 170, 643-648.
26. Romanelli F, Fillo S, Isidori A and Conte D (1997) Pituitary adenylate cyclase-activating polypeptide regulates rat Leydig cell function in vitro. Neuropeptides 314, 311-317.
27. Rossato M, Nogara A, Gottardello F, Bordon P and Foresta C (1997) Pituitary adenylate cyclase-activating polypeptide stimulates rat Leydig cell steroidogenesis through a novel transduction pathway. Endocrinology 138, 3228-3235.
28. Shioda S, Legradi G, Leung W-C, Nakajo S, Nakaya K and Arimura A (1994) Localization of pituitary adenylate cyclase-activating polypeptide and its messenger ribonucleic acid in the rat testis by light and electron microscopic immunocytochemistry and in situ hybridization. Endocrinology 135, 818-825.
29. Shivers BD, Gorcs TJ, Gottschall PE and Arimura A (1991) Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions. Endocrinology 128, 3055-3065.
30. Solano RM, Carmena MJ, Busto R, Sánchez-Chapado M, Guijarro LG and Prieto JC (1999) Identification and functional properties of the pituitary adenylate cyclase activating peptide (PAC1) receptor in human benign hyperplastic prostate. Cell Signal 11, 813-819.
31. Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG and Prieto JC (1996) Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate. Endocrinology 137, 2815-2822.
32. Waschek JA, Dicicco-Bloom EM, Leliévre V, Zhou X and Hu Z (2000) PACAP action in nervous system development, regeneration, and neuroblastoma cell proliferation. Ann NY Acad Sci 921, 129-136.
33. Xing JZ, Zhu L, Jackson JA, Gabos S, Sun X-J, Wang X-b and Xu X (2005) Dynamic monitoring of cytotoxicity on microelectronic sensors. Chem Res Toxicol 18, 154-161.
34. Yanaihara H, Vigh S, Kozicz T, Somogyvári-Vigh A and Arimura A (1998) Immunohistochemical demonstration of the intracellular localization of pituitary adenylate cyclase activating polypeptide-like immunoreactivity in the rat testis using the stamp preparation. Regal Pept 78, 83-88.
35. Yu N, Atienza JM, Bernard J, Blanc S, Zhu J, Wang X, Xu X and Abassi YA (2006) Real-time monitoring of morphological changes in living cells by electronic cell sensor arrays: An approach to study G protein-coupled receptors. Anal Chem 78, 35-43.